|142.28||+0.9500||+0.67%||Vol 326.72K||1Y Perf -9.31%|
|Jun 29th, 2022 16:03 DELAYED|
|- -%||- -|
|Target Price||178.33||Analyst Rating||Moderate Buy 2.50|
|Potential %||25.34||Finscreener Ranking||★★+ 46.89|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 45.73|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 63.67|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★ 29.82|
|Price Range Ratio 52W %||13.50||Earnings Rating||Strong Buy|
|Market Cap||17.95B||Earnings Date||25th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||25th Jul 2022|
|Estimated EPS Next Report||2.04|
|EPS Growth Next 5 Years %||46.50|
|Avg. Weekly Volume||646.94K|
|Avg. Monthly Volume||663.67K|
|Avg. Quarterly Volume||734.24K|
PerkinElmer Inc. (NYSE: PKI) stock closed at 142.28 per share at the end of the most recent trading day (a 0.67% change compared to the prior day closing price) with a volume of 326.72K shares and market capitalization of 17.95B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 14000 people. PerkinElmer Inc. CEO is Prahlad R. Singh.
The one-year performance of PerkinElmer Inc. stock is -9.31%, while year-to-date (YTD) performance is -29.24%. PKI stock has a five-year performance of 108.81%. Its 52-week range is between 132.78 and 203.16, which gives PKI stock a 52-week price range ratio of 13.50%
PerkinElmer Inc. currently has a PE ratio of 23.70, a price-to-book (PB) ratio of 2.55, a price-to-sale (PS) ratio of 3.64, a price to cashflow ratio of 14.30, a PEG ratio of 2.32, a ROA of 6.41%, a ROC of 8.67% and a ROE of 13.51%. The company’s profit margin is 14.79%, its EBITDA margin is 30.70%, and its revenue ttm is $5.02 Billion , which makes it $39.79 revenue per share.
Of the last four earnings reports from PerkinElmer Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.04 for the next earnings report. PerkinElmer Inc.’s next earnings report date is 25th Jul 2022.
The consensus rating of Wall Street analysts for PerkinElmer Inc. is Moderate Buy (2.5), with a target price of $178.33, which is +25.34% compared to the current price. The earnings rating for PerkinElmer Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
PerkinElmer Inc. has a dividend yield of 0.19% with a dividend per share of $0.28 and a payout ratio of 2.00%.
PerkinElmer Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.69, ATR14 : 4.88, CCI20 : -26.32, Chaikin Money Flow : -0.01, MACD : -1.77, Money Flow Index : 43.45, ROC : 0.27, RSI : 47.55, STOCH (14,3) : 56.95, STOCH RSI : 0.70, UO : 53.68, Williams %R : -43.05), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of PerkinElmer Inc. in the last 12-months were: Andrew Okun (Option Excercise at a value of $248 260), Andrew Okun (Sold 4 194 shares of value $788 129 ), Daniel R. Tereau (Option Excercise at a value of $443 913), Daniel R. Tereau (Sold 10 242 shares of value $1 782 614 ), James M Mock (Sold 11 105 shares of value $1 855 132 ), Sylvie Gregoire (Option Excercise at a value of $231 350), Sylvie Gregoire (Sold 5 000 shares of value $777 850 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.